Live Webinar: 26 November 2020, 10:00 – 11:00 AM EST (4:00 – 5:00 PM CET)
Featuring Megan Weivoda, USA (Michigan)
Moderated by Martina Rauner, Germany (Dresden)
- 5 min welcome & introductions
- 35 min presentations
- 20 min Q&A
- Anti-RANKL mediated disruption of bone resorption leads to a coupling-related decrease in bone formation at the gene expression level
- Bone cells exhibit changes in energy metabolism that correlate with differentiation and/or functional status
Bone resorption and formation correlate with metabolic markers, suggesting a potential coupling of bone remodeling to energy metabolism
Dr. Megan Weivoda, PhD
Megan Weivoda is an Assistant Professor in the Department of Periodontics and Oral Medicine at the University of Michigan School of Dentistry. She received her PhD in Pharmacology at the University of Iowa, completed a visiting fellowship at the University of Oxford and postdoctoral research at the Mayo Clinic in Rochester, Minnesota. Dr Weivoda previously served as Assistant Professor in the Division of Endocrinology at the Mayo Clinic. Her research programme focuses on the role of osteoclasts in the bone remodelling cycle.
Specifically, she is investigating the mechanisms by which osteoclast-mediated bone resorption activates subsequent cycles of bone formation and how this “coupling” is disrupted during ageing in order to identify novel mechanisms to stimulate bone formation. In addition, her lab is investigating the connections of ageing and senescence to cancer and inflammatory diseases. Dr Weivoda is a member of the American Society for Bone and Mineral Research (ASBMR) and the International Association for Dental Research (IADR), and currently serves as Co-Chair of the ASBMR Early Stage Investigator Subcommittee.